Mental Health Award: Funding Breakthrough Research in Drug Discovery

Admin,

Application Deadline: April 15, 2025

The global need for effective mental health treatments continues to grow, with anxiety, depression, and psychosis affecting millions worldwide. In response, a new funding initiative aims to advance target validation research for novel mental health drug discovery. This initiative seeks to support early and robust validation activities for promising therapeutic targets, ultimately leading to the development of innovative pharmacological treatments.

Overview of the Mental Health Award

This funding call, designed in collaboration with the Psychiatry Consortium, focuses on validating novel drug targets with strong biological rationale and a clear therapeutic concept. The primary goal is to generate data that supports the therapeutic potential of these targets, paving the way for groundbreaking treatments.

  • Funding Amount: Up to £700,000 per project
  • Duration: Up to two years
  • Eligibility: Open to researchers worldwide, except those based in mainland China
  • Application Deadline: Preliminary application due by April 15, 2025

Who Can Apply?

This opportunity is open to research teams specializing in mental health and drug discovery sciences. Eligible disciplines include genomics, neuroscience, molecular biology, neuropharmacology, medicinal chemistry, computational psychiatry, and related fields.

Applicants are encouraged to form diverse, interdisciplinary teams across multiple institutions. Researchers at any stage of their career are welcome to apply, and part-time researchers must commit at least 20% of their time to the project.

Eligible Organizations

Administering organizations must be able to sign Wellcome’s grant conditions and can include:

  • Higher education institutions
  • Research institutes
  • Non-academic healthcare organizations
  • Not-for-profit or non-governmental research organizations

Commercial organizations cannot apply directly but may participate as consultants or collaborators.

Research Scope and Expectations

This funding call targets research focused on validating biochemical entities that could serve as drug targets. These include:

  • Receptors
  • Proteins
  • Enzymes
  • DNA, RNA, and peptides
  • Gut microbiome elements

Successful projects should demonstrate that target modulation can lead to meaningful clinical improvements. The ultimate goal is to establish robust preclinical evidence for novel targets and facilitate their integration into drug discovery pipelines. Importantly, proposals should consider under-researched populations and ensure diversity in future drug development programs.

Mental Health Conditions in Focus

This call prioritizes early intervention in:

  • Anxiety and depressive disorders (including OCD, postpartum depression, and PTSD)
  • Psychotic disorders (such as schizophrenia, postpartum psychosis, and bipolar disorder)

While the call does not specify a diagnostic classification system, applicants must justify their chosen research framework.

Key Proposal Requirements

Successful applications must include:

  • Novelty: Demonstration of the target’s uniqueness and potential impact.
  • Biological Rationale: Strong evidence supporting the target’s role in mental health conditions.
  • Patient Impact: A clear description of the target population and potential benefits.
  • Feasibility: A detailed validation plan with well-defined milestones.
  • Expertise: A highly qualified team with relevant experience.

Research Activities Supported

The following research methodologies are encouraged:

  • In-vitro assays and cell models
  • In-vivo animal studies (including knockouts)
  • Computational neuroscience and bioinformatics
  • Genomic studies, including CRISPR applications
  • Electrophysiology, imaging, and structural biology
  • Drug repurposing with a novel target focus

Restrictions on Research Scope

Proposals that fall outside the scope of this funding include:

  • Validation of targets for conditions outside anxiety, depression, and psychosis
  • Non-pharmacological interventions
  • Research solely focused on target identification without validation
  • Drug repurposing without a novel target
  • Development of new animal or cellular models without direct validation studies

For more information and to Apply, CLICK HERE

For more opportunities such as this please follow us on Facebook , Whatsapp and Linkedin

Grants